Search results
Fall COVID shots poised for makeover
Becker’s Hospital Review· 10 hours agoAn FDA committee voted unanimously June 5 on the 2024-2025 COVID-19 vaccine makeup, recommending it should be one that targets the monovalent JN.1-lineage vaccine. Jerry Weir ...
FDA Panel Rejects MDMA Drug for PTSD
Medscape· 1 day agoA US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for ...
FDA panel supports switch to JN.1 for fall COVID vaccines
Center for Infectious Disease Research and Policy· 20 hours agoVaccine advisers to the Food and Drug Administration (FDA) today recommended switching the...
Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal - Vanda Pharma...
Benzinga· 18 minutes agoIn May, Cycle launched its sixth drug product in the U.S. market. In April, Vanda rejected Future Pak LLC’s proposal of $7.25 – $7.75 per share, saying it significantly undervalued the company ...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
KTBS Shreveport· 19 hours agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S., does the committee recommend a monovalent JN.1-lineage vaccine composition?” All 16 of the advisers ...
Judge blocks certain rules on abortion pills in North Carolina
WXII-TV Winston-Salem· 6 hours agoThe order Monday means North Carolina cannot require that only doctors prescribe the pills, that the...
Lykos' MDMA treatment rejected by FDA committee, despite being '75% of the way there'
FierceBiotech· 1 day agoLykos Therapeutics’ attempt to get the first ever MDMA treatment approved in post-traumatic stress...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 1 day agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
MPR News· 1 day agoIt represents a major setback for proponents of the drug and its sponsor Lykos Therapeutics, potentially jeopardizing FDA approval of the treatment. Following public comment ...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 19 hours agoThe Food and Drug Administration (FDA) has approved mRESVIA, a new vaccine made by Moderna, to help...
